Literature DB >> 3670291

Binding of a cellular protein to the gibbon ape leukemia virus enhancer.

J P Quinn1, N Holbrook, D Levens.   

Abstract

The gibbon ape leukemia virus (GALV) contains enhancer activity within its long terminal repeat. In the GALV Seato strain this activity resides in a 48-base-pair (bp) repeated element. We demonstrate the existence of a cellular protein which binds in this region of the Seato strain. A sensitive method for enriching protein-DNA complexes from crude extracts coupled with exonuclease and DNase footprint analysis revealed the specific binding of this protein to a 21-bp region within each repeated element. A 22-bp oligonucleotide fragment defined solely by the 21-bp footprint binds a protein in vitro and displays enhancer activity in vivo, suggesting that this protein is a major determinant of GALV enhancer activity. The protein is present in three cell lines which are positive for enhancer activity and is not detected in Jurkat cells, which are negative for enhancer activity. Only GALV long-terminal-repeat variants which support high levels of enhancer activity in vivo compete with this protein for specific binding in vitro, suggesting a potential role for the protein in determining enhancer activity. This protein binding is not inhibited by competition with heterologous retroviral enhancers, demonstrating that it is not a ubiquitous retroviral enhancer binding protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670291      PMCID: PMC367890          DOI: 10.1128/mcb.7.8.2735-2744.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Purification, structure, and properties of hybrid beta-galactosidase proteins.

Authors:  A V Fowler; I Zabin
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

2.  A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome.

Authors:  F Strauss; A Varshavsky
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

3.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

4.  Eukaryotic gene transcription with purified components.

Authors:  J D Dignam; P L Martin; B S Shastry; R G Roeder
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression.

Authors:  G M Veldman; S Lupton; R Kamen
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

6.  Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.

Authors:  J Lenz; D Celander; R L Crowther; R Patarca; D W Perkins; W A Haseltine
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

7.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses.

Authors:  D Celander; W A Haseltine
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Nucleotide sequence of the large terminal repeat of two different strains of gibbon ape leukemia virus.

Authors:  C D Trainor; M L Scott; S F Josephs; K E Fry; M S Reitz
Journal:  Virology       Date:  1984-08       Impact factor: 3.616

View more
  14 in total

1.  Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner.

Authors:  A Schmidt; L Hennighausen; U Siebenlist
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers.

Authors:  J P Quinn; M Takimoto; M Iadarola; N Holbrook; D Levens
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.

Authors:  J M Gimble; E Duh; J M Ostrove; H E Gendelman; E E Max; A B Rabson
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer.

Authors:  J P Quinn; A R Farina; K Gardner; H Krutzsch; D Levens
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

5.  Transient expression analysis of the reticuloendotheliosis virus long terminal repeat element.

Authors:  A A Ridgway; H J Kung; D J Fujita
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

6.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 7.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

8.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancer kappa E2 site.

Authors:  J M Gimble; J R Flanagan; D Recker; E E Max
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.

Authors:  C Parrott; T Seidner; E Duh; J Leonard; T S Theodore; A Buckler-White; M A Martin; A B Rabson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.